SCHEMBL1009043

SCHEMBL1009043

CC(C(=O)O)c1c(Cl)nc(Cc2ccc(N)cc2)nc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COPS5 Q92905 1/20 0.40
EGLN1 Q9GZT9 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
MAPT P10636 1/20 0.36
DHPS P49366 1/20 0.36
LMNA P02545 3/20 0.36
ALDH1A1 P00352 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
MEN1 O00255 1/20 0.36
PRNP P04156 1/20 0.36
KMT2A Q03164 1/20 0.36
PTGS1 P23219 4/20 0.36
PTGS2 P35354 4/20 0.36
AKR1C3 P42330 3/20 0.36
CYP2C9 P11712 2/20 0.36
CXCR1 P25024 2/20 0.36
CXCR2 P25025 2/20 0.36
TSHR P16473 2/20 0.36
AKR1C2 P52895 2/20 0.36
ALB P02768 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1011805 0.89 COPS5 (0.36) COPS5EGLN1L3MBTL1MAPTDHPS
SCHEMBL1009458 0.82 ACE (0.42) L3MBTL1MAPTLMNAALDH1A1MEN1
SCHEMBL1923117 0.82 ACE (0.42) L3MBTL1MAPTLMNAALDH1A1MEN1
SCHEMBL1010222 0.81 TBXA2R (0.38) COPS5EGLN1LMNAALDH1A1TDP1
SCHEMBL1924122 0.81 TBXA2R (0.38) COPS5EGLN1LMNAALDH1A1TDP1
SCHEMBL1010089 0.77 GAA (0.39) LMNAALDH1A1MEN1KMT2ACYP3A4
SCHEMBL3443252 0.75 NPSR1 (0.40) COPS5EGLN1L3MBTL1MAPTDHPS
SCHEMBL1010960 0.75 ACE (0.41) EGLN1MAPTLMNAKMT2ACYP2C9
SCHEMBL1012425 0.75 TBXA2R (0.41) EGLN1L3MBTL1MAPTLMNAALDH1A1
SCHEMBL1010138 0.74 CHRM3 (0.40) COPS5EGLN1L3MBTL1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960393-B2 Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 ACTIMIS PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
EP-1633726-B1 PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES MEDIATED BY CRTH2 ACTIMIS PHARMACEUTICALS INC (US) 2011-01-05 EP disclosed